loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Buntanetap

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Buntanetap

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Annovis Bio Gets US Patent For TBI Treatment With Buntanetap
    Annovis Bio Gets US Patent For TBI Treatment With Buntanetap

    24 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/24/2917931/0/en/Annovis-Bio-Secures-U-S-Patent-for-Treatment-of-Acute-Traumatic-Brain-Injury-with-Buntanetap.html

    GLOBENEWSWIRE
    24 Jul 2024
    Share Share
    Annovis Bio FDA-Approved To Use New Buntanetap Crystal Form
    Annovis Bio FDA-Approved To Use New Buntanetap Crystal Form

    16 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/16/2913695/0/en/Annovis-Bio-Receives-FDA-Approval-to-Transition-to-New-Crystal-Form-of-Buntanetap.html

    GLOBENEWSWIRE
    16 Jul 2024
    Share Share
    Annovis Bio Announces New Data From Phase III Parkinson's Study
    Annovis Bio Announces New Data From Phase III Parkinson's Study

    02 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/02/2907365/0/en/Annovis-Bio-Announces-New-Data-from-Phase-III-Parkinson-s-Study-Highlighting-Improvements-in-Unified-Parkinson-s-Disease-Rating-Scale-MDS-UPDRS-and-Cognition-after-Treatment-with-B.html

    GLOBENEWSWIRE
    02 Jul 2024
    Share Share
    Annovis Bio Files Patent for New Composition of Matter for Buntanetap
    Annovis Bio Files Patent for New Composition of Matter for Buntanetap

    26 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/26/2904442/0/en/Annovis-Bio-Files-Patent-for-New-Composition-of-Matter-for-Buntanetap.html

    GLOBENEWSWIRE
    26 Jun 2024
    Share Share
    Annovis Bio’s Buntanetap Found Safe &Effective in High-Risk Alzheimer's Patients
    Annovis Bio’s Buntanetap Found Safe &Effective in High-Risk Alzheimer's Patients

    11 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/11/2896720/0/en/Annovis-Bio-s-Buntanetap-Found-Safe-and-Effective-in-High-Risk-Alzheimer-s-Patients.html

    GLOBENEWSWIRE
    11 Jun 2024
    Share Share
    Annovis Unblinded Buntanetap Phase 3 Parkinson's Data
    Annovis Unblinded Buntanetap Phase 3 Parkinson's Data

    09 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/09/2878650/0/en/Annovis-Announces-Unblinding-of-the-Buntanetap-Phase-III-Data-in-Parkinson-s-Disease.html

    GLOBENEWSWIRE
    09 May 2024
    Share Share